Advertisement

Topics

Brexanolone tolerated in super-refractory status epilepticus

12:30 EDT 9 Aug 2017 | Medical Xpress

(HealthDay)—For patients with super-refractory status epilepticus (SRSE), brexanolone as adjunctive therapy is tolerated and associated with a high rate of third-line agent (TLA) weaning, according to a study published online Aug. 5 in the Annals of Neurology.

Original Article: Brexanolone tolerated in super-refractory status epilepticus

NEXT ARTICLE

More From BioPortfolio on "Brexanolone tolerated in super-refractory status epilepticus"

Quick Search
Advertisement
 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...